These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 35328829

  • 1. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
    Bette M, Cors E, Kresse C, Schütz B.
    Int J Mol Sci; 2022 Mar 21; 23(6):. PubMed ID: 35328829
    [Abstract] [Full Text] [Related]

  • 2. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C, Büning LS, Schäfer MK, Eiden LE, Weihe E, Schütz B.
    Neurobiol Dis; 2013 Jun 21; 54():32-42. PubMed ID: 23466699
    [Abstract] [Full Text] [Related]

  • 3. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A, Barhum Y, Angel A, Perets N, Steiner I, Offen D, Lev N.
    Int J Mol Sci; 2017 Aug 01; 18(8):. PubMed ID: 28763002
    [Abstract] [Full Text] [Related]

  • 4. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.
    MacLean M, Juranek J, Cuddapah S, López-Díez R, Ruiz HH, Hu J, Frye L, Li H, Gugger PF, Schmidt AM.
    J Neuroinflammation; 2021 Jun 15; 18(1):139. PubMed ID: 34130712
    [Abstract] [Full Text] [Related]

  • 5. Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival.
    Kim A, Lee DY, Sung JJ.
    J Neurochem; 2024 Sep 15; 168(9):2908-2925. PubMed ID: 38934222
    [Abstract] [Full Text] [Related]

  • 6. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S, Fabbrizio P, Amadio S, Volonté C.
    J Neuroinflammation; 2016 Aug 22; 13(1):191. PubMed ID: 27549088
    [Abstract] [Full Text] [Related]

  • 7. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE, Rasmussen AL, Bennett W, King A, West AK, Chung RS, Chuah MI.
    J Neuroinflammation; 2014 Mar 23; 11():55. PubMed ID: 24655927
    [Abstract] [Full Text] [Related]

  • 8. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G, Philips T, Van Wijmeersch B, Audet JN, Dewil M, Van Den Bosch L, Billiau AD, Robberecht W, Julien JP.
    J Neurosci; 2008 Oct 08; 28(41):10234-44. PubMed ID: 18842883
    [Abstract] [Full Text] [Related]

  • 9. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P, Zschüntzsch J, Steffens H, Scheffel J, Göricke B, Weishaupt JH, Le Meur K, Kirchhoff F, Hanisch UK, Schomburg ED, Neusch C.
    PLoS One; 2012 Oct 08; 7(8):e43963. PubMed ID: 22952827
    [Abstract] [Full Text] [Related]

  • 10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ, Ren M, Jiang HZ, Wang J, Zhang J, Yin X, Wang SY, Qi Y, Wang XD, Feng HL.
    Neuroscience; 2014 Sep 26; 277():132-8. PubMed ID: 24699224
    [Abstract] [Full Text] [Related]

  • 11. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 26; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 12. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V, Krull D, Taylor A, Dick JR, Bates SA, Cleveland MS, Prinjha RK, Greensmith L.
    Hum Mol Genet; 2014 Aug 15; 23(16):4187-200. PubMed ID: 24667415
    [Abstract] [Full Text] [Related]

  • 13. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A, Sironi F, Tortarolo M, Gatto N, De Gioia R, Pasetto L, De Paola M, Mariani A, Ghosh S, Watson R, Kalmes A, Bonetto V, Bendotti C.
    J Neuroinflammation; 2018 Mar 01; 15(1):65. PubMed ID: 29495962
    [Abstract] [Full Text] [Related]

  • 14. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
    Schütz B, Reimann J, Dumitrescu-Ozimek L, Kappes-Horn K, Landreth GE, Schürmann B, Zimmer A, Heneka MT.
    J Neurosci; 2005 Aug 24; 25(34):7805-12. PubMed ID: 16120782
    [Abstract] [Full Text] [Related]

  • 15. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK, Weston RH, Perera ND, D'Amico A, Nutt SL, Turner BJ.
    J Neuroinflammation; 2015 Feb 27; 12():40. PubMed ID: 25889790
    [Abstract] [Full Text] [Related]

  • 16. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
    Nowicka N, Zglejc-Waszak K, Juranek J, Korytko A, Wąsowicz K, Chmielewska-Krzesińska M, Wojtkiewicz J.
    PLoS One; 2024 Feb 27; 19(3):e0299567. PubMed ID: 38457412
    [Abstract] [Full Text] [Related]

  • 17. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis.
    Deng B, Lv W, Duan W, Liu Y, Li Z, Ma Y, Zhang G, Song X, Cui C, Qi X, Li Y, Li C.
    Cell Physiol Biochem; 2018 Feb 27; 46(6):2358-2372. PubMed ID: 29742495
    [Abstract] [Full Text] [Related]

  • 18. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Gento-Caro Á, Vilches-Herrando E, Portillo F, González-Forero D, Moreno-López B.
    Brain Pathol; 2022 May 27; 32(3):e13022. PubMed ID: 34585475
    [Abstract] [Full Text] [Related]

  • 19. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.
    Kreilaus F, Guerra S, Masanetz R, Menne V, Yerbury J, Karl T.
    Genes Brain Behav; 2020 Feb 27; 19(2):e12604. PubMed ID: 31412164
    [Abstract] [Full Text] [Related]

  • 20. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Bonifacino T, Cattaneo L, Gallia E, Puliti A, Melone M, Provenzano F, Bossi S, Musante I, Usai C, Conti F, Bonanno G, Milanese M.
    Neuropharmacology; 2017 Sep 01; 123():433-445. PubMed ID: 28645622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.